9 WiSys Technologies in "Diagnostic Assays" or "Information Technology" or "Pharmaceuticals & Vitamin D"
WiSys is seeking a strategic partner skilled in the development and manufacturing of membranes used for the separation and/or detection of biologic molecules in solution. There is additional interest in a partner with the expertise to identify and test novel applications for these nanomembranes.
WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.
The WiSys Technology Foundation is seeking commercial partners interested in developing anxiolytic and anticonvulsant benzodiazepines that offer little or no side effects.
WiSys is currently seeking a strategic partner to assist in such further development providing a route to market for the commercialization of lead analogues.